Sjoerd van den Berg

Dr. Sjoerd van den Berg is a Researcher at Erasmus MC in the Department of Clinical Chemistry, specializing in endocrinology and clinical pharmacology. His work focuses on metabolic disorders, immunotherapy efficacy, and long-term health outcomes in cancer survivors. He has published extensively on cortisol-related biomarkers, pharmacokinetics in obstetric conditions, and metabolic syndrome in survivor populations.

Research Interests:

• Endocrine mechanisms in chronic diseases
• Glucocorticoid metabolism and clinical applications
• Long-term effects of childhood cancer treatments
• Stress-biochemical interactions in obesity
• Immunotherapy response modulation

Recent Articles Trends: His 2025 publications emphasize cortisol's role in melanoma immunotherapy, betamethasone pharmacokinetics in pre-eclampsia, and metabolic syndrome prevalence in childhood cancer survivors. The 2024 dyslipidemia study highlights cardiovascular risks in long-term survivors through large cohort analysis.

Advising & Grants: No formal advisee listings were identified in the provided texts, though his collaborative research network suggests active team-based projects. Grant details were not explicitly mentioned.

Labs/Teams: Collaborates within Erasmus MC's clinical chemistry and oncology survivorship research groups, with international partnerships in endocrinology and pharmacology.